ArticleFrontiers in immunology2020
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.
Ralf Kircheis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
140 papers cite itlatest 60 shown
this paperpooled ittrialcites it